Search results
FY2025 EPS Estimates for Pfizer Inc. Increased by Leerink Partnrs (NYSE:PFE)
ETF DAILY NEWS· 2 days agoPfizer Inc. (NYSE:PFE – Free Report) – Equities research analysts at Leerink Partnrs boosted their FY2025 EPS estimates for shares of Pfizer in a research ...
Pfizer lifts profit forecast as CEO sees reason for optimism in 2024
Reuters via Yahoo Finance· 6 days ago(Reuters) -Pfizer lifted its annual earnings forecast on Wednesday and reported a first-quarter...
Albert Bourla
Time Magazine· 5 days agoWhen Albert Bourla became CEO of Pfizer in 2019, just before the pandemic, he wanted to make Pfizer’s medicines more affordable to more patients. “No...
What to know about the new 'FLiRT' COVID variants that are spreading: Your guide to the latest virus...
Yahoo Life· 10 hours agoHere’s your go-to guide with everything you need to know about COVID-19, including the latest...
Pfizer earnings beat by $0.29, revenue topped estimates
Investing.com· 6 days agoPfizer earnings beat by $0.29, revenue topped estimates
Pfizer (NYSE:PFE) Earns Outperform Rating from BMO Capital Markets
ETF DAILY NEWS· 2 days agoBMO Capital Markets reaffirmed their outperform rating on shares of Pfizer (NYSE:PFE – Free Report) in a report issued on Thursday, Benzinga reports. BMO Capital Markets currently ...
Pfizer's Stock Is a Buy. Here Are Six Reasons Why.
Motley Fool via Yahoo Finance· 5 days agoPfizer (NYSE: PFE) stock is an investing enigma. The drugmaker's shares have printed fresh 52-week lows consistently over the past two years, putting its...
Morgan Stanley Raises Pfizer (NYSE:PFE) Price Target to $29.00
ETF DAILY NEWS· 2 days agoPfizer (NYSE:PFE – Free Report) had its price target boosted by Morgan Stanley from $28.00 to $29.00 in a research report report published on Thursday, Benzinga reports. They ...
Pfizer Stock Jumps On 'Massive' Upside Thanks To Paxlovid Surprise
Investor's Business Daily· 5 days agoComirnaty, the Covid vaccine Pfizer developed with BioNTech (BNTX) brought in $354 million in sales,...
Pfizer Sees Less Revenue From Covid-19 Treatments, Stock Faces Headwinds Ahead Of Q1 Earnings - ...
Benzinga· 6 days agoPfizer's Q1 earnings report expects EPS of 49 cents and $13.09 billion in revenues. Stock has...